Literature DB >> 12694112

Childhood Guillain-Barré syndrome. MR imaging in diagnosis and follow-up.

A Coşkun1, S Kumandaş, A Paç, O I Karahan, M Guleç, M Baykara.   

Abstract

PURPOSE: To evaluate the value of serially obtained spinal MR images in the diagnosis and clinical follow-up of childhood Guillain-Barré syndrome (GBS), and the time period for resolution of contrast enhancement during the course of illness.
MATERIAL AND METHODS: Contrast-enhanced spinal MR images of 11 pediatric patients with GBS were reviewed prospectively. In the first group of 6 patients, follow-up MR was performed three times after the 1st, 3rd and 6th months after onset of the disease. In the second group (the other 5 patients) who had not accepted serial MR examinations, control MR was repeated once after 1 year. Patients were graded clinically into five categories according to their initial clinical signs and symptoms and three grades (mild, moderate and severe) according to level of contrast enhancement on T1-weighted images to correlate the severity of enhancement with clinical findings and recovery.
RESULTS: Ten of the 11 patients revealed contrast enhancement in varying degrees in the spinal nerve roots surrounding the conus medullaris and extending the length of the cauda equina. One patient showed no contrast enhancement. Anterior nerve roots enhanced more intensely than the posterior roots in 3 patients. Follow-up MR images in all patients revealed diminishing or resolving contrast enhancement in the nerve roots as the clinical symptoms improved.
CONCLUSION: We suggest contrast-enhanced spinal MR imaging as a supplementary diagnostic modality in diagnosing GBS, especially when the clinical and electrophysiological findings are equivocal. Follow-up images may play a role in predicting the clinical course of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 12694112     DOI: 10.1080/j.1600-0455.2003.00023.x

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  8 in total

1.  Magnetic resonance imaging of Guillain-Barré syndrome.

Authors:  Hong-Liang Zhang; Jian-Meng Wang; Hong-Wei Zhou; Jing Xu; Jiang Wu
Journal:  Childs Nerv Syst       Date:  2010-07-20       Impact factor: 1.475

2.  Gadolinium enhancement of cauda equina: a new MR imaging finding in the radiculitic form of tick-borne encephalitis.

Authors:  S Marjelund; A Jaaskelainen; T Tikkakoski; S Tuisku; O Vapalahti
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  Spinal MRI findings of guillain-barré syndrome.

Authors:  Ozlem Alkan; Tulin Yildirim; Naime Tokmak; Meliha Tan
Journal:  J Radiol Case Rep       Date:  2009-03-01

4.  Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement.

Authors:  G Zuccoli; A Panigrahy; A Bailey; C Fitz
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

5.  Magnetic resonance imaging of childhood Guillain-Barre syndrome.

Authors:  Ali Yikilmaz; Selim Doganay; Hakan Gumus; Huseyin Per; Sefer Kumandas; Abdulhakim Coskun
Journal:  Childs Nerv Syst       Date:  2010-06-17       Impact factor: 1.475

6.  West Nile virus presenting as flaccid paralysis: Case report and literature review.

Authors:  Ivan DeQuesada; Amit Saindane
Journal:  Radiol Case Rep       Date:  2015-12-07

7.  Cauda equina arachnoiditis - a rare manifestation of West Nile virus neuroinvasive disease: A case report.

Authors:  Marija Santini; Ivana Zupetic; Klaudija Viskovic; Juraj Krznaric; Marko Kutlesa; Vladimir Krajinovic; Vlatka Lovrakovic Polak; Vladimir Savic; Irena Tabain; Ljubo Barbic; Maja Bogdanic; Vladimir Stevanovic; Anna Mrzljak; Tatjana Vilibic-Cavlek
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

8.  An Unusual Presentation of Acute Weakness: Acute Inflammatory Demyelinating Polyneuropathy in a Patient with Psychiatric Illness.

Authors:  Eric Lombardi; Ryan Misek; Krishna Patel
Journal:  Case Rep Emerg Med       Date:  2018-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.